Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-17 in Chronic Inflammation: From Discovery to Targeting
Audrey Beringer, Mélissa Noack, Pierre Miossec
Trends in Molecular Medicine (2016) Vol. 22, Iss. 3, pp. 230-241
Closed Access | Times Cited: 376

Showing 1-25 of 376 citing articles:

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1194
Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Jasminka Talapko, Martina Juzbašić, Tatjana Matijević, et al.
Journal of Fungi (2021) Vol. 7, Iss. 2, pp. 79-79
Open Access | Times Cited: 446
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Alexander R. Moschen, Herbert Tilg, Tim Raine
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 3, pp. 185-196
Closed Access | Times Cited: 390
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?
Kenneth F. Baker, John D. Isaacs
Annals of the Rheumatic Diseases (2017) Vol. 77, Iss. 2, pp. 175-187
Closed Access | Times Cited: 337
Immune crosstalk in cancer progression and metastatic spread: a complex conversation
Hannah Garner, Karin E. de Visser
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 483-497
Closed Access | Times Cited: 324
IL‐17 and IL‐22 in immunity: Driving protection and pathology
Kilian Eyerich, Valentina Dimartino, Andrea Cavani
European Journal of Immunology (2017) Vol. 47, Iss. 4, pp. 607-614
Open Access | Times Cited: 301
Selected cytokine pathways in rheumatoid arthritis
Mélissa Noack, Pierre Miossec
Seminars in Immunopathology (2017) Vol. 39, Iss. 4, pp. 365-383
Closed Access | Times Cited: 289
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
José María García Ruiz de Morales, L. Puig, E. Daudén, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 1, pp. 102429-102429
Open Access | Times Cited: 271
Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage
Huimin Zhu, Zhiqiang Wang, Jixu Yu, et al.
Progress in Neurobiology (2019) Vol. 178, pp. 101610-101610
Closed Access | Times Cited: 261
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders
Patrizia Fasching, Martin Stradner, W. Graninger, et al.
Molecules (2017) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 217
Current Developments in the Immunology of Psoriasis.
Franziska Grän, Andreas Kerstan, Edgar Serfling, et al.
The Yale Journal of Biology and Medicine (2020) Vol. 93, Iss. 1, pp. 97-110
Closed Access | Times Cited: 171
Osteoimmunology in Bone Fracture Healing
T. Ono, Hiroshi Takayanagi
Current Osteoporosis Reports (2017) Vol. 15, Iss. 4, pp. 367-375
Closed Access | Times Cited: 170
Interluekin-17A (IL17A)
Kong Chen, Jay K. Kolls
Gene (2017) Vol. 614, pp. 8-14
Open Access | Times Cited: 145
IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels
Marie Robert, Pierre Miossec
Frontiers in Medicine (2019) Vol. 5
Open Access | Times Cited: 141
Effects of Interleukin 17 on the cardiovascular system
Marie Robert, Pierre Miossec
Autoimmunity Reviews (2017) Vol. 16, Iss. 9, pp. 984-991
Closed Access | Times Cited: 130
Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells
Yu Zhang, Michelle Zoltan, Erick Riquelme, et al.
Gastroenterology (2018) Vol. 155, Iss. 1, pp. 210-223.e3
Open Access | Times Cited: 127
Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity
Luciano Pirola, José Cândido Ferraz
World Journal of Biological Chemistry (2017) Vol. 8, Iss. 2, pp. 120-120
Open Access | Times Cited: 116
Immunobiology of Atherosclerosis: A Complex Net of Interactions
Beatriz Herrero‐Fernández, Raquel Gómez-Bris, Beatriz Somovilla-Crespo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5293-5293
Open Access | Times Cited: 114
The IL-23–IL-17 pathway as a therapeutic target in axial spondyloarthritis
Joachim Sieper, Denis Poddubnyy, Pierre Miossec
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 12, pp. 747-757
Closed Access | Times Cited: 108
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
Andrew Blauvelt, Melinda Gooderham, Lars Iversen, et al.
Journal of the American Academy of Dermatology (2017) Vol. 77, Iss. 5, pp. 855-862
Open Access | Times Cited: 107
The pathogenesis of thyroid autoimmune diseases: New T lymphocytes – Cytokines circuits beyond the Th1−Th2 paradigm
Qian Li, Bin Wang, Kaida Mu, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 3, pp. 2204-2216
Closed Access | Times Cited: 106
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials
Philip J. Mease, Philip Helliwell, Kasper Fjellhaugen Hjuler, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 2, pp. 185-193
Open Access | Times Cited: 106
Inhibition of Interleukin-17A, But Not Interleukin-17F, Signaling Lowers Blood Pressure, and Reduces End-Organ Inflammation in Angiotensin II–Induced Hypertension
Mohamed A. Saleh, Allison E. Norlander, Meena S. Madhur
JACC Basic to Translational Science (2016) Vol. 1, Iss. 7, pp. 606-616
Open Access | Times Cited: 104
Principles of inflammasome priming and inhibition: Implications for psychiatric disorders
Francis Herman, Giulio Maria Pasinetti
Brain Behavior and Immunity (2018) Vol. 73, pp. 66-84
Open Access | Times Cited: 102
Systemic effects of IL-17 in inflammatory arthritis
Audrey Beringer, Pierre Miossec
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 8, pp. 491-501
Closed Access | Times Cited: 102
Page 1 - Next Page

Scroll to top